Electra Therapeutics Inc. (ETRA) vs Gyre Therapeutics, Inc. (GYRE)

Electra Therapeutics Inc. ETRA 8.20 +5.13%
Gyre Therapeutics, Inc. GYRE 4.64 −2.52%

Electra Therapeutics Inc. and Gyre Therapeutics, Inc. are both Biotechnology companies. Electra Therapeutics Inc. and Gyre Therapeutics, Inc. are of similar size ($515.9M and $493.1M).

Metric	ETRA	GYRE	Biotechnology median
P/E	—	n/m	10.85
P/S	—	4.05	9.49
P/B	—	3.41	2.18
Price to free cash flow	—	n/m	25.85
EV/EBITDA	—	n/m	0.70
EV/Sales	—	3.48	8.99
Earnings yield	—	(6.03%)	(31.76%)
Free cash flow yield	—	(5.15%)	(21.84%)

Metric	ETRA	GYRE	Biotechnology median
Gross margin	—	91.71%	68.51%
Operating margin	—	0.00%	0.00%
Net margin	—	(21.46%)	0.00%
Free cash flow margin	—	(19.94%)	0.00%
Return on equity	—	(18.54%)	(50.82%)
Return on assets	—	(14.49%)	(46.04%)
Return on invested capital	—	(8.51%)	0.00%

Metric	ETRA	GYRE	Biotechnology median
Revenue growth (TTM)	—	13.51%	6.96%
EPS growth (last fiscal year)	—	(60.00%)	29.88%
Revenue growth, 5-year CAGR	—	40.96%	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	ETRA	GYRE	Biotechnology median
Debt to equity	—	0.00	0.00
Current ratio	—	4.32	4.84
Net debt to EBITDA	—	(3.74)	1.01

Metric	ETRA	GYRE	Biotechnology median
Dividend yield	—	—	0.40%
Payout ratio	—	—	—

Metric	ETRA	GYRE	Biotechnology median
Market cap	515.94m	493.06m	163.56m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack